Captek Softgel International, Inc. — Cyborg Score 7/10
Strong
Contract Manufacturing Organizations (CMOs) for Dietary Supplements
Strategic Profile
Captek operates out of three facilities in Cerritos, Vista, and La Mirada, California, totaling more than 290,000 square feet and capable of producing over 13 billion softgels annually. The company has produced over 4,000 discreet formulations in softgels and currently manufactures approximately 1,200 active products in any given year. The company offers flexibility through softgel, capsule, gummy, and tablet options with customization features including shapes, sizes, colors, flavors, and various dietary attributes.
Cyborg Score Rationale
Captek is a well-established, privately-held CMO with 30 years of industry experience, substantial manufacturing scale (13B+ softgels/year), strong regulatory compliance (FDA/GMP/NSF), and a large experienced leadership team. The company maintains high utilization rates and diversified product capabilities (softgels, capsules, gummies, tablets), but lacks public market visibility and recent disclosed growth metrics, limiting upside clarity.
Top Insights
Annual revenue of $246.4 million positions Captek as a substantial player in the contract manufacturing space
Captek has built a stellar reputation for solving complex encapsulation challenges, with unique understanding of capsule integrity and ingredient interaction valued by leading nutraceutical companies
The company maintains several industry certifications recognizing its manufacturing standards, including FDS, cGMP, NSF, and GMP
The company is positioning itself to address trending clean label, organic, vegan, and pesticide-free products, with expertise in handling highly sensitive raw ingredients such as probiotics, enzymes, and botanicals
Named Competitors
Natural Alternatives International — Contract manufacturer of dietary supplements and nutraceutical products
ANS — Competitor in contract manufacturing space
Freemen Nutra Group LLC — Nutraceutical manufacturing and operations
Recent Developments
(October 2024) Announced gummy product line expansion
(September 2024) Continued investment in dietary supplement contract manufacturing capabilities
(March 2026) ZoomInfo data reflects active hiring in Operations and Quality Control roles, indicating growth trajectory
Open the full interactive Captek Softgel International, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.